1. Home
  2. HOUR vs IXHL Comparison

HOUR vs IXHL Comparison

Compare HOUR & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

N/A

Current Price

$1.91

Market Cap

63.3M

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

N/A

Current Price

$5.88

Market Cap

97.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HOUR
IXHL
Founded
2015
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
97.6M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
HOUR
IXHL
Price
$1.91
$5.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.8K
4.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
128.57
N/A
EPS
0.07
N/A
Revenue
$138,252,861.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.40
N/A
Revenue Growth
4.64
N/A
52 Week Low
$1.10
$0.11
52 Week High
$6.84
$5.45

Technical Indicators

Market Signals
Indicator
HOUR
IXHL
Relative Strength Index (RSI) 51.83 90.18
Support Level $1.74 $0.31
Resistance Level $1.95 N/A
Average True Range (ATR) 0.04 0.37
MACD -0.00 0.40
Stochastic Oscillator 9.09 91.05

Price Performance

Historical Comparison
HOUR
IXHL

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: